Phenylpropanolamine and hemorrhagic stroke in the hemorrhagic stroke project: A reappraisal in the context of science, the food and drug administration, and the law

Annals of Epidemiology

Volumn 16, Issue 1, 2006, Pages 49-52

  Stier, Byron G ^a   Hennekens, Charles H ^b,c,d  

^a SOUTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c FLORIDA ATLANTIC UNIVERSITY   (United States)

^d Data and Safety Monitoring Boards

Author keywords

Cerebrovascular Accident; Epidemiology; Jurisprudence; Phenylpropanolamine; Public Policy

Indexed keywords

PHENYLPROPANOLAMINE;

ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; DRUG APPROVAL; DRUG INFORMATION; DRUG MARKETING; DRUG SAFETY; DRUG USE; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; LAW SUIT; MAJOR CLINICAL STUDY; MALE; ORGANIZATION AND MANAGEMENT; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STROKE;

ADOLESCENT; ADULT; BIAS (EPIDEMIOLOGY); CEREBROVASCULAR ACCIDENT; CONFOUNDING FACTORS (EPIDEMIOLOGY); DATA INTERPRETATION, STATISTICAL; DRUG APPROVAL; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; NASAL DECONGESTANTS; PHENYLPROPANOLAMINE; PRODUCT SURVEILLANCE, POSTMARKETING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 28944448885     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2005.01.012     Document Type: Article

References (23)

1. Horwitz RI, Brass LM, Kernan WN, Viscoli CM. Phenylpropanolamine & Risk of Hemorrhagic Stroke, Final Report of The Hemorrhagic Stroke Project. May 10, 2000.
2. Woodcock J, FDA. Letter. Nov. 3, 2000.
3. W.N. Kernan, C.M. Viscoli, L.M. Brass, J.P. Broderick, T. Brott, and E. Feldmann Phenylpropanolamine and the risk of hemorrhagic stroke N Engl J Med 343 2000 1826 1832
4. C.H. Hennekens, and J.E. Burring Epidemiology in Medicine 1987 Little, Brown & Co Boston
5. Voigt LV. Expert Report. In re Phenylpropanolamine Prod. Liab. Litig., No. MDL. 1407 (W.D. Wash.) (BJR). Jan. 2, 2003.
6. Horwitz RI, Brass LM, Kernan WN, Singer BH, Viscoli CM. Hemorrhagic Stroke Project: Case-Control Study of PPA and Hemorrhagic Stroke. April 1994.
7. Schlesselman JJ. Expert Report. In re Phenylpropanolamine Prod. Liab. Litig., No. MDL. 1407 (W.D. Wash.) (BJR). Jan. 6, 2003.
8. Brass LM. Deposition. In re Phenylpropanolamine Prod. Liab. Litig., No. MDL. 1407 (W.D. Wash.) (BJR). Oct. 1, 4, 10, 2002.
9. Viscoli CM. Deposition. In re Phenylpropanolamine Prod. Liab. Litig., No. MDL. 1407 (W.D. Wash.) (BJR). Oct. 21-22, 2002.
10. Kernan WN. Deposition. In re Phenylpropanolamine Prod. Liab. Litig., No. MDL. 1407 (W.D. Wash.) (BJR). Sept. 18-19, 2002.
11. Sauerbeck L. Deposition. In re Phenylpropanolamine Prod. Liab. Litig., No. MDL. 1407 (W.D. Wash.) (BJR). Nov. 13, 2002.
12. Krompf K. Deposition. In re Phenylpropanolamine Prod. Liab. Litig., No. MDL. 1407 (W.D. Wash.) (BJR). Oct. 29-30, 2002.
13. Horwitz RI, Memorandum to Guinn PF. Aug. 15, 2000.
14. Littlejohn TJ. Deposition. In re Phenylpropanolamine Prod. Liab. Litig., No. MDL. 1407 (W.D. Wash.) (BJR). Dec. 19, 2002.
15. Consumer Healthcare Products Association. Points to Consider in Review of the Hemorrhagic Stroke Project: Case-Control Study of Phenylpropanolamine (PPA) and Hemorrhagic Stroke. May 9, 2000.
16. L.L. Bronner, D.S. Kanter, and J.E. Manson Primary prevention of stroke N Engl J Med 333 1995 1392 1400
17. B.J. Feder Dow Corning in bankruptcy over lawsuits NYT 1995 A, 1. May 16, 1995
18. FDA Chronology of FDA Breast Implants Activities 2000 FDA Washington, DC Available at: http://www.fda.gov/cdrh/breastimplants/handbook2004/timeline.html Last accessed September 19, 2005
19. S.E. Gabriel, W.M. O'Fallon, L.T. Kurland, C.M. Beard, J.E. Woods, and L.J. Melton Risk of Connective-Tissue Diseases and Other Disorders after Breast Implantation N Engl J Med 330 1994 1697 1702
20. J. Sánchez-Guerrero, C.A. Colditz, E.W. Karlson, D.J. Hunter, F.E. Speizer, and L.M. Liang Silicone breast implants and the risk of connective-tissue diseases and symptoms N Engl J Med 332 1995 1666 1670
21. C.H. Hennekens, I. Lee, and N.R. Cook Self-reported breast implants and connective-tissue diseases in female health professionals JAMA 275 1996 616 621
22. Diamond BA, Hulka BS, Kerkvliet NI, Tugwell P. Silicone Breast Implants in Relation to Connective Tissue Diseases and Immunologic Dysfunction. Report by National Science Panel to the Honorable Sam C. Pointer, Jr., Coordinating Judge for the Federal Breast Implant Multidistrict Litigation. November 17, 1998.
23. S. Bondurant, V. Ernster, and R. Herdman Institute of Medicine Safety of Silicone Breast Implants 2000 National Academy Press Washington, DC www.iom.edu/report.asp?id=5638